Hunan Jingfeng Pharmaceutical Co.,Ltd. (SHE:000908)
5.49
+0.16 (3.00%)
Apr 24, 2025, 2:45 PM CST
SHE:000908 Revenue
Hunan Jingfeng Pharmaceutical had revenue of 92.12M CNY in the quarter ending September 30, 2024, a decrease of -46.85%. This brings the company's revenue in the last twelve months to 397.76M, down -49.18% year-over-year. In the year 2023, Hunan Jingfeng Pharmaceutical had annual revenue of 656.89M, down -21.86%.
Revenue (ttm)
397.76M
Revenue Growth
-49.18%
P/S Ratio
12.12
Revenue / Employee
695.39K
Employees
572
Market Cap
4.82B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 656.89M | -183.76M | -21.86% |
Jan 1, 2023 | 840.66M | 29.47M | 3.63% |
Jan 1, 2022 | 811.18M | -66.74M | -7.60% |
Dec 31, 2020 | 877.92M | -466.11M | -34.68% |
Dec 31, 2019 | 1.34B | -1.24B | -48.02% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Aier Eye Hospital Group | 20.62B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |